Rare Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Segmented By Indication (Gastroenterology Disease, Endocrine & Metabolism Disorders Disease, Cardiovascular Disorders, Hematology & Oncology Disease, Others), By Trait Type (Inherited v/s Acquired), By Test Type (Genetic Tests, General Lab Tests, Diagnostic Imaging, Others), By Technology (Next Generation Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays, Others), By Sample Type (DNA Sample, Blood Sample, Saliva Sample, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others), By company and By Region

Published	Pages	Publisher	Report code
Jun 2023	117	TechSci Research	ASDR-622675

Published: Jun 2023 - Pages : 117 - Publisher : TechSci Research - Report code : ASDR-622675

1. Agilent Technologies Inc.
2. Illumina Inc.
3. QIAGEN NV
4. PerkinElmer
Inc
5. Quest Diagnostics Inc.
6. CENTOGENE N.V.
7. 23andMe Inc.
8. 3billion Inc.
9. Eurofins Scientific SE
10. Invitae Corporation

Rare Disease Diagnostics - Global Forecast 2024-2030

This report can be of interest as well:

Rare Disease Diagnostics - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-652011

Mark your calendar:

Oligonucleotide Therapeutics and Delivery Conference 2024

09 September - 10 September, 2024
London, United Kingdom